Proteomics

Global Market Trajectory & Analytics

MCP-1029

EXECUTIVE ENGAGEMENTS

POOL

4122
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

743
Interactions with Platform & by Email

PARTICIPANTS

124
Unique # Participated

VALIDATIONS

36
Responses Validated*

COMPANIES

178
Responses Validated*
* Login for a full stack data experience

DATE

JUN 2021

TABLES

147

PAGES

577

EDITION

18

PRICE

USD 5600

CODE

MCP-1029


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

S M N T

%

VALIDATED RESEARCH *

S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T

* S = Strong; M = Moderate; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
  

HIGHLIGHTS & REPORT INDEX

Global Proteomics Market to Reach $43.5 Billion by 2026

The proteomics market is anticipated to gain from the pressing need to develop advanced therapeutic and diagnostic options in the wake of COVID-19. The ability of proteomics to help researchers in detecting several proteins in a single analysis is anticipated to make it a suitable weapon in the fight against the COVID-19 virus. Proteomics represents a highly relevant technique in the battle against COVID-19 owing to the significance to understand the role played by proteins in the infection process as well as disease progression. These insights are critical to support preventative strategies and development of novel therapeutics. The use of mass spectrometry to detect COVID-19 virus` proteins and proteolytic peptides enables a rapid, simple virus detection assay. On the other hand, targeted proteomics allows detection of peptides of the virus` spike proteins and nucleocapsid with high specificity and sensitivity in clinical and research samples. The approach holds potential to make proteomics an effective option for diagnostic laboratories along with point-of-care testing as a cost-effective alternative to techniques based on nucleic acid. Proteomics can be potentially used to develop techniques to predict COVID-19 patients who may experience severe symptoms later. Various studies have revealed potential protein-based biomarkers expressed differently among certain COVID-19 patients, which can be used for predicting viral infection during earlier stages. The use of proteomics to understand humoral antibody response against virus` proteins has facilitated the development of specific antibody-based assays intended to support diagnostic or therapeutic objectives.

Amid the COVID-19 crisis, the global market for Proteomics estimated at US$23 Billion in the year 2020, is projected to reach a revised size of US$43.5 Billion by 2026, growing at a CAGR of 10.8% over the analysis period. Reagents, one of the segments analyzed in the report, is projected to grow at a 10.6% CAGR to reach US$34.8 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 11.8% CAGR for the next 7-year period. This segment currently accounts for a 17.2% share of the global Proteomics market.

The U.S. Market is Estimated at $10.2 Billion in 2021, While China is Forecast to Reach $3.9 Billion by 2026

The Proteomics market in the U.S. is estimated at US$10.2 Billion in the year 2021. The country currently accounts for a 37.7% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$3.9 Billion in the year 2026 trailing a CAGR of 13.6% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.2% and 10.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.3% CAGR while Rest of European market (as defined in the study) will reach US$4.3 Billion by the close of the analysis period.

Major driving factors of growth in the market include growing demand for personalized medicine, growing applications of proteomics in drug discovery, rise in demand for early diagnosis and treatment of diseases, technical advancements, rise in birth disorders and genetic disorders and the rapidly growing pharmaceutical and biopharmaceutical markets. Other factors supporting growth include development of protein targeted treatments and precision molecular medicines for many autoimmune diseases, development of mass spectrometry-based proteomics, and development of molecular targets in malignancies. Increasing focus of biotechnological and pharmaceutical companies in research and development for identifying new proteomics applications, development of new drugs, and proteomics biomarker discovery in different types of diseases such as cardiovascular diseases and cancer is the major trend in the global proteomics landscape. Proteomics is extensively used in protein expression profiling, targeted protein quantitation, analysis of interactions between proteins, and post-translational modification in different segments of the pharmaceutical industry. Advanced proteomics solutions are finding extensive application in diagnostic services, drug discovery and other research fields. Proteomics is a promising approach towards personalized medicine to treat several diseases, such as diabetes, obesity, fatty liver, neurological diseases, and cancer.

In addition to the rising incidence of cancer, diabetes, and other potentially fatal diseases, there is a rise in disorders, such as autism and Alzheimer`s, which are highly wanting in terms of research and cure. Use of plasma proteomics method for proteomic biomarker identification is associated with challenges of patients` variation and high dynamic range of plasma proteins. However, increasing focus on specialty medicines due to technological advancements, sophisticated software, and tools such as IoT, data analytics, big data, and artificial intelligence in the clinical research related to proteomics could create new opportunities for the proteomics market.

Services Segment to Reach $3.3 Billion by 2026

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 9.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$2.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$314.8 Million by the year 2026.

SELECT PLAYERS

ActivX Biosciences, Inc.; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Bruker Corporation; Cytiva; Geneva Bioinformatics S.A.; Merck KGaA; PerkinElmer, Inc.; Shimadzu Corporation; Millipore Sigma; Thermo Fisher Scientific, Inc.; Waters Corp.; Xencor, Inc.

SEGMENTS

» Component (Reagents, Instruments, Services) » Application (Drug Discovery, Disease Diagnosis, Other Applications)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2020: A Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?
Impact of COVID-19 on Laboratory Equipment and Supplies Market: A General Review
Proteomics Emerges as an Important Research Tool in Battle against COVID-19
Pressing Need for COVID-19 Diagnostics & Therapeutics Accentuates Dynamic Role of Proteomics
Gaining Insights into COVID-19 & Drug Discovery with Proteomics
Proteomics to Enable Potent Antiviral Agents & Better Vaccines against COVID-19
Proteomics Labs Explore COVID-19 Therapeutic Options, Dx Development
Proteins, Proteome and Proteomics: A Prelude
Genesis of Proteomics
Important Milestones
An Insight into Proteomics Data Type and their Characteristics / Features
Proteomics and Genomics: A Comparison
Applications of Proteomics
Outlook
Proteomics at the Fore with Latest Advances
Regional Analysis
Key Challenges to Address
Sparse and Difficult to Measure Data
Democratizing Proteomics
Absence of High-Profile Projects for Stimulating Interest
Creating Novel Experimental Design
Lack of Commercialization of High Throughput Impacts
Lack of Necessary Technical Skillset
Competition
Recent Market Activity
World Brands
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Proteomics Profiling to Expedite Drug Discovery
Other Applications of Proteomics in Drug Discovery
New Proteomics Technique to Aid Drug Screening & Biomarker Discovery
Diseases as a Major Cause of Deaths Worldwide Brings to Fore the Growing Importance of New Breakthroughs in Proteomics-Based Technologies: Top Global Causes of Death (In Millions) by Type of Disease for the Years 2000 and 2019
EXHIBIT: Global Drug Discovery Market by Segment: 2020
Growing Interest in Personalized Medicine to Drive Market Growth
EXHIBIT 8: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
Oncology: A Key Focus Area for Proteomics
EXHIBIT 3: Global Breakdown of Total Number of Cancer Cases by Type: 2020
EXHIBIT 4: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Proteomic Approaches Gain Prominence in Cancer Drug Discovery
Proteomics Technologies Used in Cancer Drug Discovery and Development
Role of Proteomics in Oncology Biomarker Discovery
TABLE: List of FDA-approved Protein Biomarkers for Cancer
Advancements in Proteomics Bring Biomarkers into Limelight
Different Types of MS-Based Proteomic Discovery Techniques for Biomarkers
Affinity-Reagent-Array-Based Techniques
Affinity-and-Antibody-Based MS Techniques
CE-MS Technology: An Emerging Technology for Discovery of Biomarkers
Protein Microarrays: A Novel Tool for the Development of Pharmaceuticals
Protein Microarray Formats
New Technologies Expand Application of Proteomics
DIA Technique for Protein Discovery
AI and Machine Learning Address Shortcomings of Traditional Equipment in Effectively Identifying Protein Patterns
Bioinformatics Tools along with Proteomics Accelerate the Process of Pathway Prediction
Map of COVID-19 and Human Protein Interactions Reveals Drug Targets
Single-Cell Proteomics Offers a Better Understanding of Cellular Identity
Metalloproteomics: A Rapidly Evolving Field
Post-translational Modification of Proteins Increases Functional Diversity of Proteome
Pharmacoproteomics Holds Significant Prospects in Precision Medicine
Increasing Prominence of Nanoproteomics Widens Opportunities
Global Proteomics Sample Preparation Market
Challenges Faced
Management of Data in Proteomics Research Poses a Big challenge
Role of Contract Research Organizations to Increase in Proteomics
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
World Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Current & Future Analysis for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
UNITED STATES
USA Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
USA Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
CANADA
Canada Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Canada Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
JAPAN
Japan Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Japan Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
CHINA
China Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
China Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
EUROPE
Europe Current & Future Analysis for Proteomics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Proteomics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Europe Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
FRANCE
France Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
France Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
GERMANY
Germany Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Germany Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
ITALY
Italy Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Italy Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
UK Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
SPAIN
Spain Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Spain Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
RUSSIA
Russia Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Russia Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Rest of Europe Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Proteomics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Proteomics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
Asia-Pacific Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Asia-Pacific Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
AUSTRALIA
Australia Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Australia Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
INDIA
India Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
India Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
South Korea Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Latin America Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Middle East Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
AFRICA
Africa Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027
Africa Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027
Total Companies Profiled: 178

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com